News

Alpha Tau Medical Ltd.: Alpha Tau Announces Second Quarter 2025 Financial Results and Provides Corporate Update

FDA approval of IDE to conduct a U.S. pilot study exploring the use of Alpha DaRT in patients with recurrent glioblastoma multiforme (GBM), a highly aggressive brain cancer - - Multiple U.S. clinical ...

Key inflation rate shows biggest rise in 6 months, CPI shows, but Fed rate cut still appears in play

Someone has to pay the cost of higher U.S. tariffs — and part of the cost finally appears to be falling on consumers. A key ...
Public Broadcasting Service (PBS)8h

Tariff-driven inflation accelerating with ‘worst yet to come,’ AEI’s Michael Strain says

New inflation figures showed signs that President Trump’s tariffs are starting to have an impact on consumer prices. Overall ...

Urgent.ly targets Q3 breakeven and insurance expansion as AI platform drives operational gains

Guidance for Q3 2025 revenue ($31 million to $34 million) is consistent with the previous quarter’s Q2 guidance. Management shifted toward highlighting operational breakeven and margin improvement, ...